亞洲太平洋地區生物科技市場（2008∼2012年）

Abstract

The report “Asia Pacific Biotechnology Market (2008-2012)” provides an exhaustive view of the biotechnology markets in the Asia-Pacific region (Japan, China, Australia, South Korea, India, Taiwan, New Zealand and Singapore). It also provides a detailed account of the major factors driving growth in the biotechnology industry of the region and enabling it to become a dominant force in the future.

As per our research, countries in the Asia-Pacific region were late starters in the biotechnology market. However, the industry is growing much faster than the industries in North America and Europe, primarily due to low costs, strong government support, large talent pool and biodiversity. In future both India and China are expected to emerge as leading players in the global biotechnology market.

Information on the market size, structure, segmentation, growth, future forecasts, success and risk factors and evolving trends in technology development are thoroughly analyzed in this report.

The report also covers the fact that the biotechnology markets in the Asia-Pacific region have huge differences from one another in terms of infrastructure, funding, talent pool, growth, size and potential as an outsourcing destination. Thus, it provides valuable information to pharmaceutical & biotechnology companies and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets.

• Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion.
• Japan, China, and Australia are the three largest biotechnology markets in the Asia-Pacific region, with combined market share of around 79% in 2007. The medical biotechnology sector presently accounts for the highest share in the overall market.
• Japan remains the largest biotech market in the region; therefore, the country represents a more mature market as compared to other neighboring markets.
• China and India, with low costs and big talent pool, are likely to emerge as the most potential biotech research and manufacturing outsourcing destinations in the future.
• Asia-Pacific is expected to become a major destination for stem cell research and biogeneric manufacturing.

Key Issues and Facts

• What are the market trends in the Asia-Pacific Biotechnology industry?
• An insight into the biotechnology industries of Japan, China, India, South Korea, Australia, Taiwan, New Zealand and Singapore.
• An overview of Bioclusters in the Asia-Pacific Biotechnology industry.
• Key sectors in the Asia-Pacific Biotechnology industry.
• Course of market growth for the next 5 years.
• Opportunities that can be leveraged by the Asia-Pacific Biotechnology industry.
• Forces that are driving the biotechnology industry in the Asia-Pacific region.
• Challenges faced by the Asia-Pacific Biotechnology industry.

Research Methodology

Information has been sourced from various authentic and reliable sources like books, newspapers, trade journals & white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

The analysis methods comprise of Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis (using software tools), Judgmental Forecasting, and Cause and Effect Analysis.

Table of Contents

1. Analyst View

2. Global Biotechnology Industry Overview

• 2.1 Market Overview
  • 2.1.1 Product Segmentation
  • 2.1.2 Geographical Segmentation

3. Asia-Pacific Biotechnology Market

• 3.1 Market Overview
  • 3.1.1 Product Segmentation
  • 3.1.2 Geographical Segmentation
• 3.2 What Makes Asia-Pacific Biotech Market Capable?
  • 3.2.1 Strong Government Support
  • 3.2.2 Human Resources
  • 3.2.3 Bio-diversity
  • 3.2.4 Infrastructure
  • 3.2.5 Low Cost

4. Asia-Pacific Biotechnology Market by Country

• 4.1 Japan
  • 4.1.1 Market Overview
  • 4.1.2 Product Segmentation
  • 4.1.3 Bio-clusters
  • 4.1.4 Success & Risk Factors
  • 4.1.4.1 Success Factors
  • 4.1.4.2 Risk Factors
  • 4.1.5 Future Outlook (2008-2012)
• 4.2 China
  • 4.2.1 Market Overview
  • 4.2.2 Product Segmentation
  • 4.2.3 Bio-clusters
  • 4.2.4 Success & Risk Factors
    • 4.2.4.1 Success Factors
    • 4.2.4.2 Risk Factors
  • 4.2.5 Future Outlook (2008-2012)
• 4.3 India
  • 4.3.1 Market Overview
  • 4.3.2 Product Segmentation
  • 4.3.3 Bio-clusters
  • 4.3.4 Success & Risk Factors
    • 4.3.4.1 Success Factors
    • 4.3.4.2 Risk Factors
  • 4.3.5 Future Outlook (2008-09 to 2012-13)
• 4.4 Australia
  • 4.4.1 Market Overview
  • 4.4.2 Bio-clusters
  • 4.4.3 Success & Risk Factors
    • 4.4.3.1 Success Factors
    • 4.4.3.2 Risk Factors
  • 4.4.4 Future Outlook (2008-09 to 2012-13)
• 4.5 Taiwan
  • 4.5.1 Market Overview
  • 4.5.2 Bio-clusters
  • 4.5.3 Success & Risk Factors
    • 4.5.3.1 Success Factors
    • 4.5.3.2 Risk Factors
  • 4.5.4 Future Outlook (2008-2012)
• 4.6 South Korea
  • 4.6.1 Market Overview
  • 4.6.2 Product Segmentation
  • 4.6.3 Bio-clusters
  • 4.6.4 Success & Risk Factors
    • 4.6.4.1 Success Factors
    • 4.6.4.2 Risk Factors
  • 4.6.5 Future Outlook (2008-2012)
• 4.7 New Zealand
  • 4.7.1 Market Overview
  • 4.7.2 Product Segmentation
  • 4.7.3 Bio-clusters
  • 4.7.4 Success & Risk Factors
    • 4.7.4.1 Success Factors
    • 4.7.4.2 Risk Factors
  • 4.7.5 Future Outlook (2008-2012)
• 4.8 Singapore
  • 4.8.1 Market Overview
  • 4.8.2 Bio-clusters
  • 4.8.3 Success & Risk Factors
    • 4.8.3.1 Success Factors
    • 4.8.3.2 Risk Factors
  • 4.8.4 Future Outlook (2008-2012)

5. Emerging Sectors

• 5.1 Contract Research/Manufacturing
• 5.2 Vaccines
• 5.3 Generics
• 5.4 Stem Cell Research
• 5.5 Nanotechnology
• 5.6 Bioinformatics

6. Roadblocks

• 6.1 Lack of IPR Regime
• 6.2 Lack of Private Participation
• 6.3 Lack of Bioventures
• 6.4 Lack of Cash

7. Future Outlook

• 7.1 Increased Government Support
• 7.2 Role of Private Sector
• 7.3 Improved Intellectual Property Regime
• 7.4 Mergers & Acquisitions
• 7.5 Infrastructure Improvement
• 7.6 Sustained Growth in Revenues Through 2012

8. Competitive Landscape

• 8.1 Invitrogen Corporation
• 8.2 Takara Holdings, Inc.
• 8.3 CSL Limited
• 8.4 Biota Holdings Limited
• 8.5 GlaxoSmithKline Plc

List of Figures:

• Figure 2-1: Global - Biotechnology Market (in Million US$), 2005-2007E
• Figure 2-2: Global - Forecast for Biotechnology Market (in Million US$), 2008-2012
• Figure 2-3: Global - Biotechnology Market by Segment (%), 2006
• Figure 2-4: Global - Biotechnology Market by Region (%), 2006
• Figure 3-1: Asia-Pacific* - Biotechnology Market (in Million US$), 2005-2007
• Figure 3-2: Asia-Pacific - Biotechnology Market by Segment (%), 2006
• Figure 3-3: Asia-Pacific - Biotechnology Market by Country (%), 2007
• Figure 4-1: Japan - Biotechnology Market (in Billion JPY), 1998-2007
• Figure 4-2: Japan - Biotechnology Market by Segment (in Billion JPY), 2005 & 2007
• Figure 4-3: Japan - Biotechnology Market by Segment (%), 2005 & 2007
• Figure 4-4: Japan - Medical & Healthcare Biotechnology Market by Segment (%), 2007
• Figure 4-5: Japan - Geographical Distribution of Bio-Clusters
• Figure 4-6: Japan - Forecast for Biotechnology Market (in Billion JPY), 2008-2012
• Figure 4-7: China - Biotechnology Market (in Billion Yuan), 2005-2007E
• Figure 4-8: China - Biotechnology Market by Segment (%), 2006
• Figure 4-9: China - Forecast for Biotechnology Market (in Billion Yuan), 2008-2012
• Figure 4-10: India - Investments in Biotechnology Market (in Million US$), 2001-02 to 2007-08
• Figure 4-11: India - Biotechnology Market (in Billion INR), 2002-03 to 2007-08E
• Figure 4-12: India - Exports & Domestic Consumption of Biotechnology Market (%), 2006-07
• Figure 4-13: India - Biotech Companies by Segment (%), 2006-07
• Figure 4-14: India - Biotechnology Market by Segment (%), 2007-08E
• Figure 4-15: India - Biopharmaceutical Market by Segment (%), 2006-07
• Figure 4-16: India - Forecast for Biotechnology Market (in Billion INR), 2008-09 to 2012-13
• Figure 4-17: India - Forecast for Biotechnology Market by Segment (%), 2012-13
• Figure 4-18: Australia - Biotechnology Market (in Billion AU$), 1998-99, 2002-03 to 2007-08E
• Figure 4-19: Australia - Geographical Distribution of Bio-clusters
• Figure 4-20: Australia - Forecast for Biotechnology Market (in Billion AU$), 2008-09 to 2012-13
• Figure 4-21: Taiwan - Investments in the Biotechnology Market (in Million US$), 2006 & 2007
• Figure 4-22: Taiwan - Biotechnology Market (in Million US$), 2003-2007E
• Figure 4-23: Taiwan - Forecast for Biotechnology Market (in Million US$), 2008-2012
• Figure 4-24: South Korea - Biotechnology Market (in Million US$), 2002-2007E
• Figure 4-25: South Korea - Biotechnology Market* by Segment (%), 2004
• Figure 4-26: South Korea - Geographical Distribution of Bio-clusters
• Figure 4-27: South Korea - Forecast for Biotechnology Market (in Million US$), 2008-2012
• Figure 4-28: New Zealand - Biotechnology Market* (in Million NZ$), 1999 & 2004-2007E
• Figure 4-29: New Zealand - Biotechnology Market* by Segment (%), 2005
• Figure 4-30: New Zealand - Geographical Distribution of Bio-clusters
• Figure 4-31: New Zealand - Forecast for Biotechnology Market (in Million NZ$), 2008-2012
• Figure 4-32: Singapore - Biotechnology Market* (in Million US$), 2005-2007
• Figure 4-33: Singapore - Forecast for Biotechnology Market (in Million US$), 2008-2012
• Figure 5-1: India - Contract Research Market (in Million US$), 2002, 2006, 2007E & 2012F
• Figure 5-2: India - Contract Manufacturing Market (in Millon US$), 2004, 2006, 2007E & 2012F
• Figure 5-3: Global - Nanotechnology Applications in Life Sciences (in Billion US$), 2005E & 2010F
• Figure 7-1: Asia-Pacific* - Forecast for Biotechnology Market (in Million US$), 2008-2012
• Figure 7-2: Asia-Pacific - Forecast for Biotechnology Market by Country (%), 2012

List of Tables:

• Table 4-1: India - Top 20 Biotech Companies by Revenue (in Million INR), 2006-07
• Table 4-2: South Korea - Growth in Major Segments of Biotechnology Market (%), 1999-2004